Alexander Bobenko has spent the past 20 years chewing on mathematical doughnuts. In the 2000s, he tried to prove that compact ...

Sunday: Cloudy, with a high of 36 and low of 18 degrees. ⛄️ Brr!

Built in 1927, the owner of the cement-covered, wood-frame haunt on South Tacoma Way has slowly but surely been restoring the ...

TornadoVM, an open-source plug-in for OpenJDK and GraalVM that compiles and offloads Java code to accelerators such as GPUs, released version 2.0 last month, adding support for new data types and ...

Learn how to use advanced techniques like short-circuiting, parallel execution, virtual threads, and stream gatherers to maximize Java stream performance. My recent Java Stream API tutorial introduced ...

ROCHESTER, N.Y. — The Advance 2 Apprenticeship pre-apprenticeship program celebrated its first-ever graduating class Friday at the Finger Lakes Workforce Development Center. Fourteen people graduated ...

The ChatGPT-maker is releasing its “best model yet” as it faces new pressures from Google and other AI competitors. OpenAI has introduced GPT-5.2, its smartest artificial intelligence model yet, with ...

Rohan Best previously received funding for projects for the Economic Research Institute for ASEAN and East Asia (ERIA) and the New South Wales government. A federal government green energy program is ...

Earlier this week, it was reported that OpenAI was in a bit of a tizzy over the current state of Google’s Gemini generative AI model. A so-called “code red” declaration was made, which will reportedly ...

USDA initiated sign-up for Stage 2 of the Supplemental Disaster Relief Program at local Farm Service Agency offices on Nov. 24, with sign-up to continue until April 30, 2026. Just over $16 billion is ...

The Navy is walking away from the Constellation-class frigate program to focus on new classes of warships the service can build faster, Secretary of the Navy John Phelan announced Tuesday on social ...

Novo Nordisk is hitting the gas on amycretin development. After posting phase 2 data, the company has decided to run pivotal diabetes trials of an asset that it previously saw primarily as an obesity ...